Investors & Media
4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. 4DMT is striving to unlock the full potential of genetic medicines using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately ONE BILLION synthetic capsid sequences to invent targeted and evolved vectors for use in our products. Learn more about our pipeline HERE.
Latest Corporate Presentation
February 22, 2023 at 4:30 PM EST
February 15, 2023 at 4:20 PM EST
November 30, 2022 at 3:55 PM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.